As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

Tokenization in RWE trials can be a powerful tool to capture prospective data on patients in the real world, and technology is improving to make EHR integration and wearable data possible. RWE trials can be cost-effective and generate valuable data that can be used for future claims and registration of new drugs or devices. Watch the full video to hear Derk break down this topic even further.

Share article